Answers are grounded in this paper and cite their sources.
Elevated serum IL-6 and IL-10 at diagnosis indicate poor prognosis in pediatric mature B-cell lymphoma, suggesting enhanced risk stratification methods.
Our study suggests that elevated serum IL-6 and IL-10 levels at diagnosis are associated with poor prognosis in pediatric mature B-NHL and may have the potential to inform risk stratification. Future prospective, multi-center studies are required to validate these findings.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: